News

Approximately 15 million Americans are on a GPL-1 or better known as Ozempic, Wegovy and Zepbound but there will be upcoming changes at CVS that may make getting the drug harder and pricier. Scripta ...
Novo Nordisk’s next-gen weight loss drug and Zepbound “seem fairly equal to me,” one expert says after release of new ...
Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...
Q: My doctor is suggesting that I try taking one of those new weight loss drugs -- off-label -- to help me cut down on my alcohol consumption. Does this make any sense? -- Pat R., Ann Arbor, Michigan ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...
Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...
Expect social and relationships to change after weight loss. The more weight you lose and the more you change your lifestyle to achieve healthy weight loss, the more likely relationships are to change ...
In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...
New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
The race to develop muscle-preserving treatments alongside popular obesity drugs like Eli Lillys (NYSE:LLY) Zepbound and Novo ...
Analysts have projected that obesity drugs sales could reach $150 billion a year by the early 2030s. The unmet need to ...